Overview

Required CCSG Acknowledgement

The NCI requires that publications acknowledge the UPCI CCSG support, and they are tracking compliance. If a UPCI CCSG-supported Shared Facility provided data used in your publication, please include the following statement in the acknowledgment section of your publication(s):

"This project used the UPCI [insert name(s) of shared facility(ies)] that [is/are] supported in part by award P30CA047904."

Shared Facility Directors: Please make sure to include this statement on all of your order forms, contracts, etc. as a reminder to your users to acknowledge the UPCI CCSG support.

The Cancer Biomarkers Facility (CBF) provides UPCI researchers with direct access to genomic and proteomic services for the discovery and translation of molecular biomarkers that:

advance the current understanding of disease
drive the development of diagnostic tests; and
enable the testing of new therapies in the clinic

The CBF is composed of multiple laboratories that support targeted and systems-level investigations of cancer biology with fully integrated bioinformatics and data analysis/interpretation support. Drs. William LaFramboise and Nathan Yates co-direct the CBF, and are supported by a high performance team of experts that develop and apply rapidly evolving technologies. Click below to learn more about our services and equipment.